ISSN (Print): 1574-3624
ISSN (Online): 2212-389X

Volume 15, 3 Issues, 2020

Open Access Funding Promote Your Article

Current Signal Transduction Therapy

ISSN (Print): 1574-3624
ISSN (Online): 2212-389X

Aims & Scope Abstracted/Indexed in

Submit Abstracts / Manuscripts Online Animated Abstract Submission

Editor-in-Chief

Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK
(USA)

View Full Editorial Board

Personal Subscription

Aims & Scope

In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders.

The journal publishes timely in-depth reviews, research article and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.